This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Clark, A. F. Search for Related Content PubMed PubMed Citation Articles by Clark, A. F. Social Bookmarking                         What's this?

Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months

Department of Adolescent Psychiatry, University of Manchester and Regional Adolescent Unit, Bolton Salford Trafford Mental Health NHS Trust, Prestwich, Manchester, UK. andrew.clark{at}man.ac.uk

Little is known about the epidemiology of pharmacotherapy in the treatment of child psychiatric disorder. This study reports on the systematic prospective collection of instances of new prescribing by child and adolescent mental health services serving a population of approximately four million people in North West England. Diagnostic and demographic information regarding new prescribing by child and adolescent mental health services within Greater Manchester and Lancashire was systematically collected prospectively over two 6-month periods between 2000 and 2002. Within the 12 months studied, there were 845 instances of a drug being newly prescribed to a child or adolescent in the treatment of a psychiatric disorder. In total, 48 different drugs were prescribed for 25 different diagnoses. The eight most commonly prescribed drugs were methylphenidate, methylphenidate/placebo trial, paroxetine, fluoxetine, risperidone, imipramine, dexamphetamine and melatonin, accounting for 73% of all prescribing. There was marked variation between services in the amount of prescribing with significant correlation between prescription of stimulants and prescription of selective serotonin reuptake inhibitor antidepressants. Prescription of medications in the treatment of child psychiatric disorder has become a significant part of child and adolescent mental health practice. However, the evidence base underpinning this usage remains limited, and further high quality therapeutic clinical trials are urgently needed.

Key Words: child mental health • paediatric psychopharmacology • prescribing practices • psychiatric practice

Journal of Psychopharmacology, Vol. 18, No. 1, 115-120 (2004)
DOI: 10.1177/0269881104040249


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. J. Kalverdijk, H. Tobi, P. B. van den Berg, J. Buiskool, L. Wagenaar, R. B. Minderaa, and L. T. W. de Jong-van den Berg Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005 Psychiatr Serv, May 1, 2008; 59(5): 554 - 560. [Abstract] [Full Text] [PDF]

				D. Bramble Psychotropic drug prescribing in child and adolescent learning disability psychiatry J Psychopharmacol, July 1, 2007; 21(5): 486 - 491. [Abstract] [PDF]